Skip to content
lifestyle.nextmentors.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
LeonaBio, Inc.
LeonaBio Reports Third Quarter 2026 Financial Results and Provides Business Update
November 16, 2026
LeonaBio to Participate in Cantor Global Healthcare Conference 2026
September 3, 2026
LeonaBio Reports Second Quarter 2026 Financial Results and Provides Business Update
August 17, 2026
LeonaBio to Highlight Lasofoxifene in ER-positive (ER+), HER2-negative, ESR1-mutated Metastatic Breast Cancer at DAVA Oncology’s 4th Summit on Breast Cancer
August 12, 2026
LeonaBio Presents on ATH-1105 at 5th Annual ALS Drug Development Summit
June 4, 2026
LeonaBio to Participate in Upcoming Medical and Industry Meetings in June
May 27, 2026
LeonaBio to Host Virtual Key Opinion Leader Event Highlighting Potential of Lasofoxifene in Treatment-Resistant ER+/HER2-, ESR1-Mutated Metastatic Breast Cancer
April 29, 2026